Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCCAN: Rimonabant in Cannabis Dependence
NCT00656487Phase 2Completed
- Sponsor
- Scripps Research
- Start
- Apr 2008
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of rimonabant in cannabis use disorder (CUD) and cannabis withdrawal, sponsored by Scripps Research. Primary endpoint: Marijuana Withdrawal Checklist at 28 days. Started Apr 2008; status: completed.
02
Drugs
rimonabant
03
Conditions
cannabis use disorder (CUD)cannabis withdrawal
Beyond the preview
Go deeper on NCT00656487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00656487.